Delta 9 Cannabis Kapitalrendite
Was ist das Kapitalrendite von Delta 9 Cannabis?
Kapitalrendite von Delta 9 Cannabis Inc. ist -22,318.47%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Health Care Sektor auf TSX im Vergleich zu Delta 9 Cannabis
Was macht Delta 9 Cannabis?
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of August 24, 2021, it owned and operated 13 retail stores under the Delta 9 brand name. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.
Unternehmen mit kapitalrendite ähnlich Delta 9 Cannabis
- Asian Mineral Resources hat Kapitalrendite von -66,919.47%
- Safe Orthopaedics SA hat Kapitalrendite von -63,940.00%
- Abal plc hat Kapitalrendite von -48,340.56%
- Portofino Resources hat Kapitalrendite von -28,221.69%
- Netlinkz hat Kapitalrendite von -23,753.85%
- RenoWorks Software hat Kapitalrendite von -23,364.71%
- Delta 9 Cannabis hat Kapitalrendite von -22,318.47%
- Genesys Industries hat Kapitalrendite von -22,032.06%
- Genesys Industries hat Kapitalrendite von -22,032.06%
- Genesys Industries hat Kapitalrendite von -22,032.06%
- Roadrunner Transportation Systems hat Kapitalrendite von -18,544.30%
- Roadrunner Transportation Systems Inc hat Kapitalrendite von -18,544.30%
- SELLAS Life Sciences Inc hat Kapitalrendite von -17,349.62%